Insider Selling: Omada Health (NASDAQ:OMDA) CEO Sells $509,530.64 in Stock

Omada Health, Inc. (NASDAQ:OMDA) CEO Sean Duffy sold 21,572 shares of the business’s stock in a transaction on Tuesday, September 1st. The stock was sold at an average price of $23.62, for a total transaction of $509,530.64. Following the transaction, the chief executive officer owned 411,861 shares of the company’s stock, valued at approximately $9,728,156.82. The trade was a 4.98% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink.

Omada Health Stock Performance

OMDA opened at $22.77 on Friday. The business’s 50-day simple moving average is $22.70 and its 200-day simple moving average is $17.58. The company has a market cap of $1.39 billion, a P/E ratio of 455.40 and a beta of 1.86. Omada Health, Inc. has a one year low of $10.28 and a one year high of $26.92.

Omada Health (NASDAQ:OMDA) last released its quarterly earnings data on Thursday, August 6th. The company reported $0.08 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.02) by $0.10. The company had revenue of $87.83 million for the quarter, compared to analysts’ expectations of $80.93 million. Omada Health had a net margin of 1.39% and a return on equity of 2.60%. As a group, analysts predict that Omada Health, Inc. will post 0.09 earnings per share for the current fiscal year.

Institutional Trading of Omada Health

Large investors have recently made changes to their positions in the stock. Raymond James Financial Inc. purchased a new stake in Omada Health during the 2nd quarter worth about $32,000. Bellevue Group AG lifted its holdings in Omada Health by 0.7% in the 3rd quarter. Bellevue Group AG now owns 251,791 shares of the company’s stock valued at $5,567,000 after purchasing an additional 1,791 shares in the last quarter. Quarry LP acquired a new stake in shares of Omada Health during the 4th quarter worth about $29,000. Barclays PLC grew its holdings in shares of Omada Health by 14.6% during the fourth quarter. Barclays PLC now owns 14,850 shares of the company’s stock worth $234,000 after buying an additional 1,888 shares in the last quarter. Finally, Versant Capital Management Inc raised its position in shares of Omada Health by 319.3% in the second quarter. Versant Capital Management Inc now owns 2,998 shares of the company’s stock valued at $66,000 after buying an additional 2,283 shares during the last quarter.

Analysts Set New Price Targets

A number of brokerages have recently commented on OMDA. Canaccord Genuity Group upped their target price on shares of Omada Health from $24.00 to $28.00 and gave the company a “buy” rating in a report on Tuesday, July 21st. Wall Street Zen upgraded shares of Omada Health from a “hold” rating to a “buy” rating in a research report on Saturday, August 8th. Morgan Stanley restated an “overweight” rating and issued a $30.00 price target on shares of Omada Health in a report on Monday, June 22nd. Weiss Ratings raised shares of Omada Health from a “sell (e+)” rating to a “sell (d+)” rating in a research note on Tuesday, August 11th. Finally, BMO Capital Markets restated an “outperform” rating and set a $24.00 target price on shares of Omada Health in a research report on Friday, August 7th. Eleven investment analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, Omada Health currently has a consensus rating of “Moderate Buy” and a consensus target price of $26.50.

Omada Health Company Profile

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.